| __timestamp | Evotec SE | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 1488000000 |
| Thursday, January 1, 2015 | 18343000 | 1525000000 |
| Friday, January 1, 2016 | 18108000 | 2111000000 |
| Sunday, January 1, 2017 | 17614000 | 1848000000 |
| Monday, January 1, 2018 | 35619000 | 1213000000 |
| Tuesday, January 1, 2019 | 58432000 | 1010000000 |
| Wednesday, January 1, 2020 | 63945000 | 997000000 |
| Friday, January 1, 2021 | 72200000 | 967000000 |
| Saturday, January 1, 2022 | 76642000 | 838000000 |
| Sunday, January 1, 2023 | 57519000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, research and development (R&D) budgets are pivotal. Over the past decade, Teva Pharmaceutical Industries Limited and Evotec SE have showcased contrasting R&D strategies. Teva, a global leader, consistently allocated substantial resources, peaking in 2016 with a 63% increase from 2014. However, by 2022, their R&D expenses had decreased by 60%, reflecting strategic shifts or market challenges.
Conversely, Evotec SE, a dynamic player in drug discovery, demonstrated a steady upward trajectory. From 2014 to 2022, Evotec's R&D budget surged by over 500%, highlighting their commitment to innovation and growth. This stark contrast underscores the diverse approaches within the industry, where established giants and agile innovators navigate the complexities of drug development. As we look to the future, these trends offer valuable insights into the strategic priorities shaping the pharmaceutical sector.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Biogen Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc.